On April 1st 2021 a new Organisation focused on producing cancer real world evidences, came into legal being – the DIGital Institute for Cancer Outcomes REsearch (DIGICORE).
DIGICORE’s objectives are to help the cancer community for the digital revolution that will transform research through the routine use of electronic health records (EHR) and molecular diagnostic information (MDX) for trial automation, outcomes research, digital diagnostics and care quality management.
DIGICORE is set-up as a European Economic Interest Grouping with 18 prominent cancer centres and 2 cancer networks, UNICANCER and Alleanza Contro il Cancro, as Members. Two commercial partners have joined this ambitious endeavour: IQVIA, the leading contract research organisation and Illumina, the global leader in DNA sequencing and bioinformatics. These commercial parties have been chosen to ensure medical hypothesis neutrality.